Mark Crotty

Mark Crotty Email and Phone Number

Interim Chief Executive Officer @ LumaCina - Bridgewest Perth Pharma
Gordon, NSW, AU
Mark Crotty's Location
Gordon, New South Wales, Australia, Australia
Mark Crotty's Contact Details
About Mark Crotty

A senior leader passionate about innovation and transformation/change management. Extensive experience with multi-national companies across Europe, Australia and New Zealand. Experience across a diverse range of industry sectors including healthcare (Medical Devices ; Wound care ;Retail and Hospital Generic medicines; Brand Pharmaceutical's, Over the counter pharmacy medicines ), beverages and FMCG packaged goods.Career achievements include:- leading a start up business, under the JUNO banner, in the Hospital generics sector resulting in a successful sale in 2023- leading the performance turnaround in Hospira ANZ (2013/15) to no 1 hospital generics position - Chairperson for the Australia Generics medicines association (GMiA) from July 2013 resulting in 5 year agreement with the Australia government- refocusing the South Europe (Ireland, Portugal, Greece, Belgium, Switzerland and Austria) Pfizer generics business through the European financial crisis (2011/12)- launch of a Greenfields business unit (Pfizer Established Products) and executed major innovations including a direct to pharmacy distribution model (2010); business development (60+ generic molecules) and pharmacy channel partnerships (Actavis)- the introduction of new marketing initiative's at Pfizer Australia involving the pitching of the $20 million account and revitalizing major brand campaigns (2008)- Creation and leadership of a industry lobby group for the US pharma companies in New Zealand (2006)- achievement of upper quartile ranking in employment satisfaction surveys (as measured by Gallup) in ANZ (2010)and Europe (2012)- launch of numerous new marketing initatives such as the launch of DB Bitter; the first every TV advertisment for beer in NZ and an advertising Axis award for Viagra

Mark Crotty's Current Company Details
LumaCina - Bridgewest Perth Pharma

Lumacina - Bridgewest Perth Pharma

View
Interim Chief Executive Officer
Gordon, NSW, AU
Website:
lumacina.com.au
Employees:
10
Mark Crotty Work Experience Details
  • Lumacina - Bridgewest Perth Pharma
    Interim Chief Executive Officer
    Lumacina - Bridgewest Perth Pharma
    Gordon, Nsw, Au
  • Crotty Laxon Pty Ltd
    Director
    Crotty Laxon Pty Ltd Oct 2023 - Present
    Sydney, New South Wales, Australia
    Services cover shorter term contract roles in Management Leadership roles; advising on strategy and change management and Board roles
  • Juno Pharmaceuticals Pty Ltd
    Ceo And Managing Director
    Juno Pharmaceuticals Pty Ltd Sep 2016 - Oct 2023
    Melbourne And Sydney
    Juno Pharmaceuticals Australia/NZ was acquired by Arrotex Pharmaceuticals in July 2023 (a division of the DBG Group; a privately owned healthcare company with a presence in Australia and New Zealand) I held a minority shareholding in the business.From its inception in 2013, Juno grew to be the leading supplier of generic and biosimilar injectable medicines to Australian hospitals. This was achieved through a B 2 B strategy, through licensing in and partnering with suppliers primarily from Europe and Asia. My role is to lead the business through a rapid expansion process achieved by bringing into the business an experienced team managing hospital generic and biosimilar medicines and working closely with the major shareholder groups and BoardThe Juno role allowed me to develop skills leading a start up business in particular managing the capital to fund a rapidly growing business. Working closely with an experienced management team and Board allowed the business to grow by 40% over the Covid period; and achieve the key measures in our sector of Top Ranked Supplier; Market leader by Sales Revenue and EBITDA above the sector average
  • Smith & Nephew
    Managing Director Australia/Nz
    Smith & Nephew Oct 2015 - Aug 2016
    Sydney Area, Australia
    Leading the ANZ organisation. Role formed due to the merging of all the S&N business units into one organisation based out of Sydney. Annual revenue approx UD $320mm and 350 employees.Market leader in medical devices and specialist wound care portfolios
  • Hospira
    Vice President Australia & New Zealand
    Hospira Feb 2013 - Sep 2015
    Melbourne Area, Australia
    Country Manager for the Hospira business. The business works across three main sectors - medical devices; hospital generics and specialist brands. The business is a market leader in the hospital generics area.
  • Generic And Biosimilars Medicines Association (Australia)
    Chairman
    Generic And Biosimilars Medicines Association (Australia) Jul 2013 - Jul 2015
    Canberra, Australia
    Chairperson role of the industry sector for the generics and biosimilars trade industry association (previously known as the GMiA). This role was served concurrently with my responsibilities as VP ANZ Hospira. The GBMA represented the interests of members who provided over 90% of generic and biosimilar medicines in the Australian marketThe major achievements in my tenure were the appointment of a successful new CEO; the development of a strategic plan; the historic signing of a 5 year agreement with the Federal government and leading the development on policy issues for the new class of biosimilar medicines.
  • Crottylaxon Pty Ltd
    Director
    Crottylaxon Pty Ltd Sep 2012 - Feb 2013
    Sydney
    Management consulting services in Australia and New Zealand. The key areas of focus are strategic projects; developing of business plans and sales and marketing.
  • Pfizer Europe
    Vice President Pfizer South Cluster Europe Establsihed Products Bu
    Pfizer Europe Mar 2011 - Aug 2012
    Switzerland
    I led an organisation of six countries (Austria, Belgium, Greece, Ireland, Portugal and Switzerland) in the off patent medicines sector. Annual Revenues USD$625 million. 175 employees. Primary capabilities inspire country managers; refocus business through economic crisis reforms; innovate and P&L responsibility
  • Pfizer Australia
    General Manager - Australia/New Zealand
    Pfizer Australia Dec 2008 - Jun 2011
    Sydney, Australia
    General manager for a greenfields business for Pfizer. Launched and developed the off patent (Established Products) business. The organisation grew through organic and M&A from approx $170MM to $340MM in 3 years. The major focus was preparing Pfizer for the patent expiry of $1 billion of brands (Lipitor $620MM); defending the current in line business and developing a generics business. The organisation grew from 18 to 90 colleagues
  • Pfizer Australia
    Brand Marketing Director
    Pfizer Australia Feb 2007 - Dec 2008
    Sydney
    Brand caretaker for a $1 billion portfolio comprising a spend of $50MM and a team off 55 marketers and competitve intellience and market researchersPart of Australia Senior Leadership team and on local Pfizer Board
  • Pfizer
    General Manager Pfizer New Zealand
    Pfizer 2000 - 2006
    Pfizer New Zealand
    General Manager for Pfizer New Zealand and for the Pharmaceuticals Group.This role involved providing leadership for the overall organisation and P&L responsibility for the Pharma group.Major focus were:- Direct to Consumer advertising for brands such as Viagra and Lipitor- Negotiation with the government on the funding of medicines- Leadership on external trade organisations such as the American PhARMA group of companies- Integration leader for two M&As with Warner Lambert and Pharmacia
  • Warner Lambert
    Business Unit Manager - Nz
    Warner Lambert 1993 - 2000
    New Zealand
    Leader for the NZ business. This involved the management of mutiple businesses - Pharma, Pharmacy OTC and FMCGThe areas of focus were:- the launch of the largest global medicine Lipitor- the switch from Pharmacy only to open sellers (grocery) for a range of medicines- the leadership of the joint venture between Parke Davis and Wellcome (1993-95)
  • Wellcome
    Sales And Marketing Manager
    Wellcome 1992 - 1993
    Auckland ; New Zealand
    Managed the Pharmacy only brands for the Wellcome NZ organisation. Full P&L responsibility with a sales and marketing team
  • Db Breweries
    Brand Marketing Manager
    Db Breweries 1990 - 1993
    New Zealand
    Marketing leader for a range of beer brands. The most significant were the launch of a new brand, DB Bitter and revitalisation of Double Brown. I was also heavily involved in new television and sponsorships around teams such as NZ Cricket and the then Auckland Warriors
  • Heinz Wattie'S - An Hj Heinz Company
    Group Product Manager - Dogfood Brands
    Heinz Wattie'S - An Hj Heinz Company 1988 - 1990
    Auckland; New Zealand
    Managing the dogfood portfolio at a time Uncle Bens (Mars Corportation) entered the market. major tasks involved building the brands via brand extensions; sponsorships and consumer advertising
  • Lion Co
    Product Manager - Steinlager; Lion Red; Waikato
    Lion Co 1986 - 1988
    Auckland; New Zealand
    Responsible for management of the annual brand plan and execution of strategies for major Lion brands. The brand portfolio was Steinlager, Waikato and Lion Red involving supporting sponsorships around - "Drinking our Beer Here" Americas Cup, the All Blacks and Kiwis.
  • R&W Hellaby
    Brand Manager
    R&W Hellaby 1983 - 1984
    New Zealand
    Managing a range of smallgoods brands

Mark Crotty Skills

Strategy Fmcg Strategic Planning Marketing Management Pharmaceutical Industry Business Development Sales Effectiveness P&l Management Change Management Marketing Strategy Business Strategy Healthcare Business Planning Leadership Brand Management Innovation Management Management Full P&l Responsibility People Development Marketing Alcoholic Beverages Advertising Management Consulting Fast Moving Consumer Goods Cultural Transformation Board Of Directors Sales Sales Management Board Of Director Experience Mergers

Mark Crotty Education Details

Frequently Asked Questions about Mark Crotty

What company does Mark Crotty work for?

Mark Crotty works for Lumacina - Bridgewest Perth Pharma

What is Mark Crotty's role at the current company?

Mark Crotty's current role is Interim Chief Executive Officer.

What is Mark Crotty's email address?

Mark Crotty's email address is ma****@****ira.com

What is Mark Crotty's direct phone number?

Mark Crotty's direct phone number is +614241*****

What schools did Mark Crotty attend?

Mark Crotty attended University Of Waikato, University Of Auckland, University Of Waikato.

What skills is Mark Crotty known for?

Mark Crotty has skills like Strategy, Fmcg, Strategic Planning, Marketing Management, Pharmaceutical Industry, Business Development, Sales Effectiveness, P&l Management, Change Management, Marketing Strategy, Business Strategy, Healthcare.

Not the Mark Crotty you were looking for?

  • Mark Crotty

    Digital Transformation Consultant | Sap S/4Hana Public Cloud Specialist | Grow With Sap | Grow With Sap For Scale-Ups
    Barcelona
  • Mark Crotty

    Customer Account Manager
    Cleveland, Oh
    4
    gmail.com, constantaviation.com, wsa.aero, weststaraviation.com

    3 +121626XXXXX

  • Mark Crotty

    Executive Director At Northwest Association Of Independent Schools
    Seattle, Wa
    3
    stjohnsschool.org, greenhill.org, nwais.org
  • Mark Crotty

    Managing Director (Ceo Australia/Nz) At Wagner Australia
    Greater Melbourne Area
    1
    cemaust.com.au

    1 +614290XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.